PGEN Logo

Precigen, Inc. (PGEN) 

NASDAQ
Market Cap
$391.25M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
91 of 809
Rank in Industry
70 of 445

Largest Insider Buys in Sector

PGEN Stock Price History Chart

PGEN Stock Performance

About Precigen, Inc.

Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.

Insider Activity of Precigen, Inc.

Over the last 12 months, insiders at Precigen, Inc. have bought $2.62M and sold $650,097 worth of Precigen, Inc. stock.

On average, over the past 5 years, insiders at Precigen, Inc. have bought $18.83M and sold $10.26M worth of stock each year.

Highest buying activity among insiders over the last 12 months: KIRK RANDAL J () — $6.26M. Hassan Fred (director) — $4.99M. Frank Steven (director) — $688,000.

The last purchase of 96,686 shares for transaction amount of $136,327 was made by KIRK RANDAL J () on 2023‑12‑28.

List of Insider Buy and Sell Transactions, Precigen, Inc.

2023-12-28SaleKINDLER JEFFREY Bdirector
96,686
0.039%
$1.41$136,3270.00%
2023-12-28PurchaseKIRK RANDAL J
96,686
0.039%
$1.41$136,3270.00%
2023-09-22PurchaseMITCHELL DEAN Jdirector
25,000
0.0099%
$1.41$35,250-1.43%
2023-08-25SaleSabzevari HelenPresident and CEO
76,969
0.0243%
$1.53$117,763-19.65%
2023-08-24SalePerez Jeffrey ThomasSVP, IP Affairs
8,891
0.0034%
$1.64$14,581-9.15%
2023-08-24SaleLehr Donald P.Chief Legal Officer
10,947
0.0042%
$1.64$17,953-9.15%
2023-08-24SaleThomasian Harry Jr.Chief Financial Officer
9,045
0.0035%
$1.64$14,834-9.15%
2023-08-24SaleShah Rutul RChief Operating Officer
5,388
0.0021%
$1.64$8,836-9.15%
2023-08-18SaleSabzevari HelenPresident and CEO
55,855
0.0225%
$1.66$92,719-13.66%
2023-08-17SalePerez Jeffrey ThomasSVP, IP Affairs
8,741
0.0031%
$1.55$13,549-19.19%
2023-08-17SaleLehr Donald P.Chief Legal Officer
10,762
0.0038%
$1.55$16,681-19.19%
2023-08-17SaleThomasian Harry Jr.Chief Financial Officer
8,893
0.0031%
$1.55$13,784-19.19%
2023-08-17SaleShah Rutul RChief Operating Officer
5,298
0.0019%
$1.55$8,212-19.19%
2023-08-16PurchaseKIRK RANDAL J
119,411
0.0466%
$1.51$180,311-8.55%
2023-08-15PurchaseKIRK RANDAL J
380,589
0.1477%
$1.52$577,301-9.15%
2023-08-14PurchaseFrank Stevendirector
400,000
0.1622%
$1.72$688,000-16.26%
2023-08-14PurchaseHassan Freddirector
570,345
0.2353%
$1.75$998,104-16.26%
2023-08-11SaleSabzevari HelenPresident and CEO
41,436
0.0152%
$1.44$59,668-9.57%
2023-08-10SalePerez Jeffrey ThomasSVP, IP Affairs
8,956
0.0028%
$1.21$10,837-8.22%
2023-08-10SaleLehr Donald P.Chief Legal Officer
11,026
0.0034%
$1.21$13,341-8.22%

Insider Historical Profitability

4.02%
Sabzevari HelenPresident and CEO
1560004
0.6267%
$1.55123<0.0001%
KIRK RANDAL J
1096686
0.4406%
$1.556912+7.38%
Frank Stevendirector
882358
0.3545%
$1.5510
Hassan Freddirector
878942
0.3531%
$1.5520<0.0001%
Perez Jeffrey ThomasSVP, IP Affairs
458903
0.1844%
$1.55220<0.0001%
Lehr Donald P.Chief Legal Officer
428916
0.1723%
$1.55221+21.62%
MITCHELL DEAN Jdirector
356836
0.1434%
$1.5520<0.0001%
KINDLER JEFFREY Bdirector
238275
0.0957%
$1.5522<0.0001%
Thomasian Harry Jr.Chief Financial Officer
161051
0.0647%
$1.5535<0.0001%
Shah Rutul RChief Operating Officer
133474
0.0536%
$1.5514<0.0001%
Ares Trading S.A.10 percent owner
20647152
8.2947%
$1.55167+52.74%
Sterling Rick L.Chief Financial Officer
340020
0.1366%
$1.55013
Reed Thomas D.Chief Science Officer
148888
0.0598%
$1.5529+21.52%
Frost Gregory IanSVP--Health Sector
100000
0.0402%
$1.5530<0.0001%
LIFFMAN JOEL DSVP, Finance
85541
0.0344%
$1.5512<0.0001%
SHAPIRO ROBERT Bdirector
82966
0.0333%
$1.5520<0.0001%
Bostick ThomasChief Operating Officer
74280
0.0298%
$1.5505
Krishnan SumaSVP--Product Development
42000
0.0169%
$1.5512+59.01%
Krishnan Krish SChief Operating Officer
42000
0.0169%
$1.5512+59.01%
Walsh Robert F. IIISVP, Energy & Fine Chem.
28816
0.0116%
$1.5502
Kasser Thomas R.SVP--Food Sector
15000
0.006%
$1.5520+19.61%
Nimrodi NirChief Business Officer
5708
0.0023%
$1.5521<0.0001%
Last Andrew J.Chief Operating Officer
4000
0.0016%
$1.5520+0.56%
Huang KellySVP-Consumer Sector
3200
0.0013%
$1.5510+59.01%
Gupta Vinita Ddirector
3000
0.0012%
$1.5510<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Patient Capital Management Llc$25.31M6.9117.45M+9.2%+$2.13M1.23
BlackRock$15.03M4.1110.36M-6.81%-$1.1M<0.0001
The Vanguard Group$9.81M2.686.77M+0.29%+$28,818.75<0.0001
Geode Capital Management$4.4M1.23.03M+0.32%+$13,904.17<0.0001
State Street$4.1M1.122.83M+5.25%+$204,329.67<0.0001
Iridian Asset Management Llc Ct$3.03M0.832.09M+4.31%+$125,192.990.6
D. E. Shaw & Co.$2.59M0.711.78M+76.82%+$1.12M<0.01
Millennium Management LLC$1.99M0.541.37M-51.84%-$2.14M<0.01
JPMorgan Chase$1.88M0.511.29M-3.62%-$70,429.41<0.0001
Northern Trust$1.57M0.431.08M-0.01%-$195.75<0.0001
Charles Schwab$1.55M0.421.07M+5.86%+$85,708.04<0.0001
Morgan Stanley$1.54M0.421.06M-15.9%-$291,422.34<0.0001
Renaissance Technologies$1.53M0.421.05M+20.35%+$257,991.01<0.01
Opaleye Management Inc$1.37M0.38947,500-6.42%-$94,250.000.22
SMH CAPITAL INC.$1.02M0.28705,000New+$1.02M0.19
Nuveen$775,725.000.21534,9830%+$0<0.0001
Emfo Llc$753,239.000.21519,4750%+$00.7
ClariVest Asset Management LLC$693,680.000.19478,400+0.19%+$1,297.750.07
BNY Mellon$583,607.000.16402,487-9.84%-$63,675.39<0.0001
MSD Partners LP$514,750.000.14355,0000%+$00.04
Citadel Advisors LLC$460,021.000.13317,256-40.31%-$310,682.66<0.0001
Fore Capital Llc$444,847.000.12306,791-14.01%-$72,500.012.77
Advisor Group Holdings Inc$433,030.000.12298,642-4.3%-$19,482.16<0.01
Goldman Sachs$412,433.000.11284,436-0.22%-$919.30<0.0001
Fidelity Investments$370,671.000.1255,635-0.11%-$407.45<0.0001
Cetera Advisors LLC$366,553.000.1252,795New+$366,553.00<0.01
Gsa Capital Partners Llp$324,000.000.09223,288-60.93%-$505,216.130.03
RhumbLine Advisers$294,539.000.08203,137-2.34%-$7,051.12<0.0001
Exchange Traded Concepts, LLC$288,920.000.08199,255+111.77%+$152,487.930.01
AllianceBernstein$267,917.000.07184,7700%+$0<0.0001
UBS$246,377.000.07169,915-20.81%-$64,729.52<0.0001
Cibc Private Wealth Group Llc$237,625.000.07166,1710%+$0<0.0001
T. Rowe Price$240,000.000.07165,152+3.32%+$7,707.81<0.0001
Panagora$226,509.000.06156,213-48.51%-$213,399.54<0.01
LINSCO PRIVATE LEDGER CORP$222,574.000.06153,499+269.89%+$162,400.33<0.0001
Bank of America$191,676.000.05132,190-63.2%-$329,179.86<0.0001
Barclays$164,000.000.05113,296-45.15%-$134,974.02<0.0001
Summit Trail Advisors$151,567.000.04104,5290%+$0<0.01
Two Sigma Advisers LP$145,000.000.04100,000-0.6%-$870.00<0.0001
Wells Fargo$140,984.000.0497,231-1.38%-$1,969.09<0.0001
Jane Street Capital$133,317.000.0491,943-55.41%-$165,667.86<0.0001
Lexaurum Advisors Llc$129,291.000.0489,166-8.8%-$12,470.030.04
Cary Street Partner Investment Advisory Llc$124,516.000.0385,8730%+$00.01
Cambridge Investment Research Advisors Inc$113,000.000.0378,184+12.68%+$12,718.72<0.0001
Tudor Investment Corp Et Al$103,623.000.0371,4640%+$0<0.01
MetLife Investment Management$98,120.000.0367,669+2.27%+$2,182.25<0.01
Virtus ETF Advisers LLC$99,708.000.0368,764-6.41%-$6,833.860.03
Hightower Advisors$97,000.000.0369,100-19.51%-$23,517.24<0.0001
American International Group$94,072.000.0364,877-3.4%-$3,310.36<0.0001
American Financial Group$96,000.000.0366,1140%+$00.04